Clinical Trial Update: A Study of Bevacizumab (Avastin®) in Combination With Temozolomide and Radiotherapy in Participants With Newly Diagnosed Glioblastoma [Phase 3]

View source ↗

Summary

Phase 3 trial of bevacizumab with temozolomide and radiotherapy in newly diagnosed glioblastoma completed; results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Bevacizumab (bevacizumab)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Glioblastoma | Phase 3 | Status: COMPLETED | Results posted: 2013-05-20